# Advisor Review - GPT-5.4 (R1)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-04-02T01:51:00.636847
**Route:** OpenRouter + LaTeX
**Paper Hash:** 50965c1d40d4270d
**Tokens:** 16544 in / 1709 out
**Response SHA256:** af0f381524fec89f

---

I checked the paper only for fatal errors in the four requested categories.

Findings:
- **Data-design alignment:** No fatal mismatch found. The treatment years discussed for the empirical design (2017, 2018, 2019, 2022) are all within the stated data window (2017–2026), and the paper explicitly describes post-treatment observations for each treated cohort, including the limited-pre-period issue for CT/RI.
- **Regression sanity:** I found no impossible or obviously broken regression outputs in the tables. Coefficients, standard errors, and reported confidence-style quantities are numerically plausible. No negative SEs, no impossible \(R^2\), and no NA/NaN/Inf entries appear in the reported results tables.
- **Completeness:** Regression tables report standard errors and sample sizes. I did not find placeholder entries such as TBD/TODO/XXX/NA in the substantive results tables. All tables and figures cited in the text are labeled in the manuscript.
- **Internal consistency:** The main numerical claims in the text are broadly consistent with the tables (allowing for rounding), including the 43% pooled effect calculation, severity decompositions, and the distinction between NY and pooled specifications. I did not identify a contradiction severe enough to block submission.

ADVISOR VERDICT: PASS